GILD News 91.50 08/04/2014 05:14:34 Gilead Sciences (GILD)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gilead Sciences (GILD) 91.50 $GILD

Doctor Evidence Partnering with Healthcare Decision-Makers on Hepatitis C Evidence
PRWeb - Sun Aug 03, 5:30AM CDT
Doctor Evidence ("DRE" , the Santa Monica, California-based healthcare information leader has responded to marketplace clamor related to the transformative innovations in Hepatitis C virus (HCV) treatments with a comprehensive comparative effectiveness database that allows healthcare decision-makers to quickly identify and synthesize available evidence in this evolving market. The DRE HCV Data Hub-currently being used by an increasing number of payers, provider groups, guideline developers and manufacturers--provides the body of published evidence around HCV screening, diagnosis and treatment in a universally transparent and accessible software-service model. The initial wave of engagements and questions across these stakeholders is facilitating evidence-based decisions regarding patient subgroup considerations, coverage decisions, treatment comparisons, and to inform evolving research and real-world evidence opportunities.

TAL Education, Team Health Join The IBD 50 Resistance
at Investor's Business Daily - Fri Aug 01, 6:08PM CDT
Leading stocks took their licks in the past week, with only a small clique of IBD 50 stocks posting weekly gains. Among those, China-based TAL Education (XRS) hauled in an 11% gain to end the week at a new high. That left the chain of tutoring...

Final Glance: Biotechnology companies
AP - Fri Aug 01, 5:03PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:

Midday Glance: Biotechnology companies
AP - Fri Aug 01, 12:35PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.:

Pharmacyclics Q2 Earnings Get Mixed Reception
at Investor's Business Daily - Fri Aug 01, 11:35AM CDT
Biotech Pharmacyclics (PCYC) was seesawing on the stock market today after its Q2 sales beat consensus late Thursday, but the company declined to update its guidance. Pharmacyclics' sales more than doubled over the year-earlier quarter to $113...

Early Glance: Biotechnology companies
AP - Fri Aug 01, 10:08AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:

Shares of GILD Up 27.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Aug 01, 9:45AM CDT
SmarTrend identified an Uptrend for Gilead Sciences (NASDAQ:GILD) on April 22nd, 2014 at $72.56. In approximately 3 months, Gilead Sciences has returned 27.17% as of today's recent price of $92.27.

Oregon Medicaid targets expensive hepatitis drug
By JONATHAN J. COOPER - AP - Thu Jul 31, 9:09PM CDT
WILSONVILLE, Ore. (AP) — An Oregon Medicaid committee on Thursday significantly scaled back access to an effective — but expensive — new drug used to treat hepatitis C.

Stock Market News for July 31, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 9:10AM CDT
Benchmarks ended Wednesday’s choppy trading session little changed after the Federal Reserve offered a mixed view on the economy

Biotech Earnings Put These ETFs in Focus - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Jul 31, 9:01AM CDT
Following solid results from Amgen, among others, these biotech ETFs could be ones to watch.

Complete Response Letter from FDA, Positive Opinion on Drug, Technical Update, Financial Result Release, and Clinical Trial Results - Research Reports on AcelRx, Horizon, Gilead, AbbVie and Exelixis
PR Newswire - Thu Jul 31, 8:20AM CDT
Today, Analysts Review released its research reports regarding AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX), Horizon Pharma Inc. (NASDAQ: HZNP), Gilead Sciences Inc. (NASDAQ: GILD), AbbVie Inc. (NYSE: ABBV) and Exelixis Inc. (NASDAQ: EXEL). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5305-100free.

Market Momentum on Biotech Stocks -- IsoRay, Neurocrine Biosciences, OPKO Health, Orexigen Therapeutics, and Gilead Sciences
PR Newswire - Thu Jul 31, 7:40AM CDT
On Wednesday, July 30, 2014, the NASDAQ Composite ended at 4,462.90, up 0.45%, the Dow Jones Industrial Average finished the day 0.19% lower at 16,880.36, and the S&P 500 closed at 1,970.07, up 0.01%. During the session five out of ten sectors ended in positive. The S&P 500 Health Care Sector Index ended the day at 718.94, up 0.36%, and the index has advanced 2.05% in the last one month. Investor-Edge has initiated coverage on the following equities: IsoRay Inc. (NYSE MKT: ISR), Neurocrine Biosciences Inc. (NASDAQ: NBIX), OPKO Health Inc. (NYSE: OPK), Orexigen Therapeutics Inc. (NASDAQ: OREX), and Gilead Sciences Inc. (NASDAQ: GILD). Free research on these five companies can be accessed at:

Biotech Valuations Are Low Not Stretched. Here's Why.
at The Street - Thu Jul 31, 7:35AM CDT
If biotech companies can assuage concerns about long-term growth, multiples might expand.

Can the Earnings Rebound be Sustained? - Earnings Outlook
Sheraz Mian - Zacks Investment Research - Thu Jul 31, 2:34AM CDT
Can the Earnings Rebound be Sustained? - Earnings Outlook

Can the Earnings Rebound be Sustained? - Earnings Trends
Sheraz Mian - Zacks Investment Research - Thu Jul 31, 2:34AM CDT
Can the Earnings Rebound be Sustained? - Earnings Trends
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 8

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 8

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 6

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 7

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 8

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 7

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 3

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading

Top 5 Most Recently Viewed Articles

Sampo plc Expands Share Buyback Program to EUR 475 Million

Updated Category News Views 98

Sampo plc Boosts Share Buyback Program Sampo plc has recently made a significant decision to enhance its share buyback program, demonstrating its dedication to delivering value to its shareholders. The company has raised the total funds allocated for buybacks from EUR 400 million to a remarkable EUR 475 million. This move reflects Sampo's adaptable financial strategies...

Continue Reading
Fundraising Milestone: bioAffinity Technologies Secures $1.2M

Updated Category News Views 142

bioAffinity Technologies Completes Successful Capital Raise bioAffinity Technologies, Inc. has made a significant step forward by securing approximately $1.2 million. This achievement comes through a private placement of shares and a concurrent warrant inducement transaction. The firm, recognized for its focus on noninvasive tests for early-stage cancer detection, has...

Continue Reading
Gran Tierra Energy's i3 Energy Acquisition Approved by Shareholders

Updated Category News Views 79

Gran Tierra Energy Inc. Secures Shareholder Approval for i3 Energy Acquisition Gran Tierra Energy Inc. (“Gran Tierra”) is excited to share that i3 Energy plc's shareholders have given their stamp of approval for the acquisition of i3 Energy. This significant milestone marks a major step forward for Gran Tierra as it continues to expand its footprint in the energy...

Continue Reading
Exploring the Growth of Single-Use Bioreactors by 2034

Updated Category News Views 148

Understanding the Expanding Single-Use Bioreactors Market The global market for single-use bioreactors is undergoing significant transformations, projected to expand from USD 4.42 billion in 2024 to an impressive USD 10.42 billion by 2034, growing at a remarkable compound annual growth rate (CAGR) of 9.0%. This transformation indicates a robust demand for innovative and...

Continue Reading
Leadership Change at Tecan as CFO Tania Micki Moves On

Updated Category News Views 307

Leadership Change at Tecan Group Tecan Group has confirmed that Chief Financial Officer Tania Micki will be departing from the company as she embarks on a new professional journey. Tania has been a pivotal member of the Management Board since February 2020, making substantial contributions to the company's financial operations. A Smooth Transition Ahead In a bid to ensure...

Continue Reading